Look for:

Our offer for

ROCHE HOLDINGS AG GENUSSCHEINE NPV


ISIN:
CH0012032048
WKN:
1203204
- -
Price
-
Difference - (-)

General attributes

ISINCH0012032048
SymbolROG
Exchange-
Currency-
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)188,696 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open-
High-
Low-
Close (prev. day)-
VWAP-
Volume (pcs)-
Trading volume-
Number of trades-
Last size-

Futures and Options

Related Futures30
Related Options-

PDF Downloads

Company report: ROCHE HOLDINGS AG GENUSSCHEINE NPVPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



- -
Price
-
Difference - (-)

General attributes

ISINCH0012032048
SymbolROG
Exchange-
Currency-
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)188,696 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open-
High-
Low-
Close (prev. day)-
VWAP-
Volume (pcs)-
Trading volume-
Number of trades-
Last size-

Performance and Risk

6m1Y3Y
Perf (%)+14.26%+30.72%+7.52%
Perf (abs.)+30.70+57.83+17.21
Beta1.171.060.87
Volatility14.9516.7817.02
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)247.22 - (1,726)
Ø price 30 days | Ø volume 30 days (pcs.)242.82 - (1,762)
Ø price 100 days | Ø volume 100 days (pcs.)240.03 - (2,259)
Ø price 250 days | Ø volume 250 days (pcs.)224.48 - (2,127)
YTD High | date254.55 - (2019/06/20)
YTD Low | date214.00 - (2019/01/02)
52 Weeks High | date254.55 - (2019/06/20)
52 Weeks Low | date188.24 - (2018/06/29)

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2130&ID_TYPE_IMAGE_LOGO=2

Contact Details

ROCHE HOLDING AG
- -
Grenzacherstrasse 124 - 4058 Basel
Telefon: +41-61-688-11-11
Fax: +41-61-691-93-91
E-mail: -

PDF Downloads

Company report: ROCHE HOLDINGS AG GENUSSCHEINE NPVPDF Download

Company Profile

Roche Holding AG is a research healthcare company. It operates through the Pharmaceuticals and Diagnostics segments. The Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Members of Management Board

Severin SchwanChairman of Managing Board
Alan HippeMember of Executive Committee
Cristina A. WilburMember of Executive Committee
Thomas SchineckerMember of Executive Committee
William AndersonMember of Executive Committee

Board of directors

Akiko IwasakiMember of the administrative board
Claudia DyckerhoffMember of the administrative board
Jemilah MahmoodMember of the administrative board
Joerg DuschmaleMember of the administrative board
Patrick FrostMember of the administrative board
Richard LiftonMember of the administrative board
Ulf Mark SchneiderMember of the administrative board
André HoffmannMember of the administrative board
Anita HauserMember of the administrative board
Bernard PoussotMember of the administrative board
Severin SchwanChairman of the administrative boar





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer